This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuspiel, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Neuspiel, D. R.
Related Collections
Right arrow Epidemiology

AAP Grand Rounds 2:34 (1999)
© 1999 American Academy of Pediatrics

EPIDEMIOLOGY

Ascorbic Acid and Blood Lead

Source: Simon JA, Hudes ES. Relationship of ascorbic acid to blood lead levels. JAMA. 1999;281:2289–2293.

The first 20% of the full text of this article appears below.

A nimal studies have suggested that oral ascorbic acid may chelate lead and decrease its toxic effects. However, small-scale human studies have not demonstrated a consistent beneficial effect. To examine the relationship of serum ascorbic acid and the prevalence of elevated blood lead levels, Simon and Hudes conducted a cross-sectional analysis of a probability sample of the US population enrolled in the . . . [Full Text of this Article]

Daniel R. Neuspiel, MD, MPH, FAAP
Pediatrics, Epidemiology and Social Medicine, Albert Einstein College of Medicine and Beth Israel Medical Center, New York, NY